The first stop for professional medicines advice

Guidance

664 results

Applied filters

Managing COVID-19 Vaccines: Guidance and SOPs

19 August 2022A series containing guidance and Standard Operational Procedures (SOPs) for managing COVID-19 vaccines

Management review and KPIs in pharmacy technical services

20 November 2024An SPS Quality Assurance (QA) bite size learning event on quality management review and key performance indicators (KPIs) in pharmacy technical services.
Registration required

Management of Particulate Contamination of Aseptically Prepared Products - NHS Pharmaceutical Quality Assurance Committee Guidance Note

24 November 2020Management of Particulate Contamination of Aseptically Prepared Products – NHS Pharmaceutical Quality Assurance Committee Guidance Note

Making unlicensed medicines

30 November 2023Medicines may be made without the need for a marketing authorisation in some circumstances

Making best use of restricted aseptic compounding capacity

18 September 2018The NHS is experiencing considerable challenges regarding the supply of aseptically prepared injectable medicines. This communication from NPSG advises all NHS customers of commercial aseptic…

MSATS – Safe use of valproate

28 February 2024Discussion of key current medication safety challenges within healthcare with a focus on the safe use of valproate; inspiring partnership across the system

MSATS event: medication safety inequalities

27 September 2023Discussion of key current medication safety challenges within healthcare with a focus on medication inequalities; inspiring partnership across the system.

MSATS - Safe Use of DOACs

30 October 2024Discussion of key current medication safety challenges within healthcare with a focus on the safe use of DOACs; inspiring partnership across the system.

MAOI to other antidepressants: switching in adults

17 February 2023Switching between or from a monoamine oxidase inhibitor (MAOI) is a complex switch and requires support from a specialist. General principles are described.

Lidocaine: informing intrathecal risk assessment

11 August 2022Lidocaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
admin